Scientists test new therapy for deadly brain tumors in mice
Researchers at UC San Francisco successfully removed aggressive childhood brain cancer from every mouse tested using a novel immune cell treatment.
The team utilized a specific immune cell therapy that turns on specifically once it reaches the skull. This approach allows the system to fight cancer without harming other parts of the animal. The design ensures the cells remain dormant until they arrive at their target site.
Diffuse midline glioma is a heartbreaking diagnosis because it grows into the brainstem. Almost every child with this illness passes away inside twelve months. Existing treatments have struggled to stop its progression, making this new experimental method a potential lifeline for patients.
The engineered cells were programmed to recognize brain proteins and then hunt for cancer cells carrying specific tumor markers. This clever design meant the immune cells did not depend on a tumor mutation to start their attack. They used a protein found naturally in the brain tissue as the trigger to begin.
Nearly seven weeks after the initial treatment, researchers introduced new cancer cells into mice that had already received the therapy. Every mouse given the treatment successfully fought off the new cells, proving the therapy provided lasting protection. The original tumors were destroyed and the disease did not return again.
“Mice with DMG are being cured, and we are incredibly excited to bring this therapy to the children and young adults we care for.”

